{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:15:33Z","timestamp":1753892133155,"version":"3.41.2"},"reference-count":5,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2023.1210185","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:46:20Z","timestamp":1684302380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: State-of-the-art rational nanodesign: from screening to theranostics and from bench to clinic"],"prefix":"10.3389","volume":"14","author":[{"given":"Alicia","family":"Fernandez-Fernandez","sequence":"first","affiliation":[]},{"given":"Romila","family":"Manchanda","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Manuel","family":"Cunha Rodrigues","sequence":"additional","affiliation":[]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/ph14080707","article-title":"Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives","volume":"14","author":"Anjum","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"103300","DOI":"10.1016\/j.jddst.2022.103300","article-title":"Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer","volume":"71","author":"Loo","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","article-title":"Nanomedicine-based commercial formulations: Current developments and future prospects","volume":"53","author":"Thapa","year":"2023","journal-title":"J. Pharm. Investigation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/nano11123346","article-title":"Nanomaterials as promising theranostic tools in nanomedicine and their applications in clinical disease diagnosis and treatment","volume":"11","author":"Zhu","year":"2021","journal-title":"Nanomater. (Basel)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1210185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:46:32Z","timestamp":1684302392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1210185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":5,"alternative-id":["10.3389\/fphar.2023.1210185"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1210185","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"article-number":"1210185"}}